维普期刊资源整合服务平台（V6.5）

50篇 您的检索式：作者名="FARLOW M"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer's disease: a review 显示文摘	KURZ A FARLOW M LEFEVRE G	2009	3(5): 799-8052009，3，5：	1
2	Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial显示文摘	TARIOT P N FARLOW M R GROSSBERG G T	2004	JAMA2004，291，3：	1
3	Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors 显示文摘	Gauthier S Emre M Farlow MR	2003	Curr Med Res Opin2003，19，8：	1
4	Phase 3 trials of solanez- umab and bapineuzumab for Alzheimer~s disease 显示文摘	Doody RS Farlow M Aisen PS	2014	N Engl J Med2014，370，15：	1
5	High levels of Alzheimer be- ta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression 显示文摘	Sokol D K Chen D Farlow M R	2006	J Child Neurol2006，21，6：	1
6	Low cerebrospinal-fluid concentrations of soluble amyloid beta-protein precursor in hereditary Alzheimer's disease显示文摘	Farlow M Ghetti B Benson MD	1992	Lancet1992，340，：	1
7	Analysis of outcome in retrieved dropout patients in a rivastigmine vs planbo,26-week,Alzheimer disease trial显示文摘	Potkin S koumaras B	2003	Arch Neurol2003，60，6：	1
8	A phase 3 trial of semagaces- tat for treatment of Alzheimer's disease显示文摘	Doody R S Raman R Farlow M	2013	N Engl J Med2013，369，4：	1
9	Low cerebrospinal-fluid concentrations of soluble amyloid beta-protein precursor in hereditary Alzheimer's disease显示文摘	Farlow M Ghetti B Benson MD		0，，8817：	1
10	Nonsense-mediated decayenables intron gain in Drosophila显示文摘	Farlow A Meduri E Dolezal M	2010	PLoS Genet2010，6，10：	1
11	Effective pharmacologic management of Alzheimer' s disease显示文摘	Farlow M R Cummings J L	2007	Am J Med2007，120，：	1
12	Phase 3 trials ofso- lanezumab for mild-to-moderate Alzheimer's disease显示文摘	Doody RS Thomas RG Farlow M	2014	N Engl J Med2014，370，4：	1
13	Phase 3 trials of solanezumab for mild-to-moderate Alzheimer' s disease 显示文摘	Doody R S Thomas R G Farlow M	2014	N Engl J Med2014，370，4：	1
14	Theropod locomotion显示文摘	FARLOW J O GATESY S M HOLTZ T R	2000	American Zoologist2000，40，：	1
15	A multi-analyte serum test for the detection of non-small cell lung cancer显示文摘	Farlow E C Vercillo M S Coon J S	2010	Br J Cancer2010，103，8：	1
16	A controlled trial of tacrine in Alzheimer's disease,The Tacrine Study Group显示文摘	Farlow M Gracon SI Hershey LA	1992	JAMA1992，268，18：	1
17	Phase 3 trials of solan- ezumab for mild-to-moderate Alzheimer's disease显示文摘	Doody RS Thomas RG Farlow M	2014	N Engl J Med2014，370，4：	1
18	Lipid homeostasis and apolipoprotein E in the development and progression of alzheimer's disease显示文摘	LANE R M FARLOW M R	2005	Journal of Lipid Research2005，46，：	1
19	Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer' s disease显示文摘	Schneider LS Farlow M Henderson VW	1996	Neurology1996，46，：	1
20	Mernantine treatment in patients with moderate to severe Alzheimer ' s disease already receiving donepezil: a randomized controlled trial 显示文摘	TARIOT P N FARLOW M R GROSSBERG G T	2004	JAMA2004，291，3：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示